Sanofi (SNW2) — Financial Flexibility Index

Latest as of September 2025: 0.07x

Sanofi (SNW2) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of €3.75 Billion (operating CF €3.75 Billion minus capex €0.00) represents 0% of total liabilities (€56.26 Billion). Check asset allocation strategy of Sanofi to assess the company's strategic physical and investment asset allocation.

Financial Flexibility Index

0.07x
Free Cash Flow / Total Liabilities

Free Cash Flow

€3.75 Billion
Operating CF − Capex

Total Liabilities

€56.26 Billion
EUR

Capital Expenditures

€0.00
EUR

Sanofi Financial Flexibility Index (2016–2024)

Historical Financial Flexibility Index trend for Sanofi across 9 annual periods. See SNW2 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Annual Financial Flexibility Index for Sanofi (2016–2024)

Year-by-year free cash flow to debt coverage for Sanofi. For the full company profile including market capitalisation, see SNW2 stock market capitalisation.

Year Flexibility Index Free Cash Flow (EUR) Operating CF Total Liabilities YoY Change
2024 0.22x €12.28 Billion €9.08 Billion €54.94 Billion ▼ -12.3%
2023 0.25x €13.28 Billion €10.26 Billion €52.11 Billion ▲ +7.3%
2022 0.24x €12.13 Billion €10.53 Billion €51.07 Billion ▲ +1.4%
2021 0.23x €12.00 Billion €10.52 Billion €51.21 Billion ▲ +38.9%
2020 0.17x €8.67 Billion €7.42 Billion €51.38 Billion ▲ +0.1%
2019 0.17x €9.04 Billion €7.71 Billion €53.63 Billion ▲ +26.8%
2018 0.13x €6.96 Billion €5.55 Billion €52.37 Billion ▼ -37.0%
2017 0.21x €8.77 Billion €7.38 Billion €41.57 Billion ▼ -0.2%
2016 0.21x €9.92 Billion €7.84 Billion €46.95 Billion
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities